President Donald J. Trump has signed an Executive Order aimed at enhancing domestic pharmaceutical manufacturing. This initiative seeks to bolster the production of prescription drugs, focusing on essential ingredients and materials.
The Executive Order is part of a broader effort to eliminate bureaucratic hurdles that hinder critical domestic pharmaceutical production. The administration describes this move as part of a strategy to "usher in America’s new Golden Age by ensuring access to the medicines Americans need."
The order also emphasizes prioritizing American manufacturing facilities over foreign ones, aligning with President Trump's commitment to "put America first." The administration asserts that this action will help secure national prosperity and protect national security.
